Education
About Us
Working with TipRanks
Follow Us
Tetralogic Pharma (TLOG)
OTHER OTC:TLOG
Total Valuation
Tetralogic Pharma has a market cap or net worth of $24.00. The enterprise value is ―.
Market Cap$24.00
Enterprise Value―
Share Statistics
Tetralogic Pharma has 24,465,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,465,000
Owned by Insiders―
Owned by Institutions0.02%
Financial Efficiency
Tetralogic Pharma’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee0.00
Employee Count29
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tetralogic Pharma is 0.00. Tetralogic Pharma’s PEG ratio is ―.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Tetralogic Pharma had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income0.00
Net Income0.00
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -23.88M and capital expenditures -666.00, giving a free cash flow of -23.88M billion.
Operating Cash Flow-23.88M
Free Cash Flow-23.88M
Free Cash Flow per Share-0.98
Dividends & Yields
Tetralogic Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-3.32
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Tetralogic Pharma upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Tetralogic Pharma as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Tetralogic Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Tetralogic Pharma EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Tetralogic Pharma has $5.89M in cash and marketable securities with $30.81M in debt, giving a net cash position of $24.92M billion.
Cash & Marketable Securities$5.89M
Total Debt$30.81M
Net Cash$24.92M
Net Cash Per Share$1.02
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tetralogic Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―